nach oben

Journal of Inherited Metabolic Disease

Erschienen in:

01.01.2012 | Review

Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management

verfasst von: Nuria Carrillo-Carrasco, Randy J. Chandler, Charles P. Venditti

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Combined methylmalonic acidemia and homocystinuria, cblC type, is an inborn error of intracellular cobalamin metabolism with a wide spectrum of clinical manifestations that is stated to be the most common inherited disorder of cobalamin metabolism. This metabolic disease is caused by mutations in the MMACHC gene and results in impaired intracellular synthesis of adenosylcobalamin and methylcobalamin, cofactors for the methylmalonyl-CoA mutase and methionine synthase enzymes. Elevated methylmalonic acid and homocysteine with decreased methionine production are the biochemical hallmarks of this disorder. Awareness of the diverse clinical presentations associated with cblC disease is necessary to provide a timely diagnosis, to guide management of affected individuals and to establish a framework for the future treatment of individuals detected through expanded newborn screening. This article reviews the biochemistry, clinical presentations, genotype-phenotype correlations, diagnosis and management of cblC disease.

Nur mit Berechtigung zugänglich

Abels J, Kroes AC, Ermens AA, van Kapel J, Schoester M, Spijkers LJ, Lindemans J (1990) Anti-leukemic potential of methyl-cobalamin inactivation by nitrous oxide. Am J Hematol 34:128–131PubMedCrossRef

Andersson HC, Marble M, Shapira E (1999) Long-term outcome in treated combined methylmalonic acidemia and homocystinemia. Genet Med 1:146–150PubMedCrossRef

Andersson HC, Shapira E (1998) Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). J Pediatr 132:121–124PubMedCrossRef

Augoustides-Savvopoulou P, Mylonas I, Sewell AC, Rosenblatt DS (1999) Reversible dementia in an adolescent with cblC disease: clinical heterogeneity within the same family. J Inherit Metab Dis 22:756–758PubMedCrossRef

Banerjee R (2006) B12 trafficking in mammals: A for coenzyme escort service. ACS Chem Biol 1:149–159PubMedCrossRef

Banerjee R, Gherasim C, Padovani D (2009) The tinker, tailor, soldier in intracellular B12 trafficking. Curr Opin Chem Biol 13:484–491PubMedCrossRef

Bartholomew DW, Batshaw ML, Allen RH, Roe CR, Rosenblatt D, Valle DL, Francomano CA (1988) Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria. J Pediatr 112:32–39PubMedCrossRef

Ben-Omran TI, Wong H, Blaser S, Feigenbaum A (2007) Late-onset cobalamin-C disorder: a challenging diagnosis. Am J Med Genet A 143A:979–984PubMedCrossRef

Bodamer OA, Rosenblatt DS, Appel SH, Beaudet AL (2001) Adult-onset combined methylmalonic aciduria and homocystinuria (cblC). Neurology 56:1113PubMed

Boneh A, Greaves RF, Garra G, Pitt JJ (2002) Metabolic treatment of pregnancy and postdelivery period in a patient with cobalamin A disease. Am J Obstet Gynecol 187:225–226PubMedCrossRef

Boxer AL, Kramer JH, Johnston K, Goldman J, Finley R, Miller BL (2005) Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment. Neurology 64:1431–1434PubMedCrossRef

Brandstetter Y, Weinhouse E, Splaingard ML, Tang TT (1990) Cor pulmonale as a complication of methylmalonic acidemia and homocystinuria (Cbl-C type). Am J Med Genet 36:167–171PubMedCrossRef

Brunel-Guitton C, Costa T, Mitchell GA, & Lambert M (2010) Treatment of cobalamin C (cblC) deficiency during pregnancy. J Inherit Metab Dis

Brunelli SM, Meyers KE, Guttenberg M, Kaplan P, Kaplan BS (2002) Cobalamin C deficiency complicated by an atypical glomerulopathy. Pediatr Nephrol 17:800–803PubMedCrossRef

Byck S, Rosenblatt DS (1991) Metabolic cooperation among cell lines from patients with inborn errors of vitamin B12 metabolism: differential response of cblC and cblD. Clin Invest Med 14:153–159PubMed

Carmel R, Bedros AA, Mace JW, Goodman SI (1980) Congenital methylmalonic aciduria–homocystinuria with megaloblastic anemia: observations on response to hydroxocobalamin and on the effect of homocysteine and methionine on the deoxyuridine suppression test. Blood 55:570–579PubMed

Carrillo-Carrasco N, Sloan J, Valle D, Hamosh A, Venditti CP (2009) Hydroxocobalamin dose escalation improves metabolic control in cblC. J Inherit Metab Dis 32:728–731PubMedCrossRef

Cerone R, Schiaffino MC, Caruso U, Lupino S, Gatti R (1999) Minor facial anomalies in combined methylmalonic aciduria and homocystinuria due to a defect in cobalamin metabolism. J Inherit Metab Dis 22:247–250PubMedCrossRef

Chace DH, DiPerna JC, Kalas TA, Johnson RW, Naylor EW (2001) Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. Clin Chem 47:2040–2044PubMed

Chadefaux-Vekemans B, Rolland MO, Lyonnet S, Rabier D, Divry P, Kamoun P (1994) Prenatal diagnosis of combined methylmalonic aciduria and homocystinuria (cobalamin CblC or CblD mutant). Prenat Diagn 14:417–418PubMedCrossRef

Chenel C, Wood C, Gourrier E, Zittoun J, Casadevall I, Ogier H (1993) Neonatal hemolytic-uremic syndrome, methylmalonic aciduria and homocystinuria caused by intracellular vitamin B 12 deficiency. Value of etiological diagnosis. Arch Fr Pediatr 50:749–754PubMed

De Bie I, Nizard SD, Mitchell GA (2009) Fetal dilated cardiomyopathy: an unsuspected presentation of methylmalonic aciduria and hyperhomocystinuria, cblC type. Prenat Diagn 29:266–270PubMedCrossRef

Deodato F, Rizzo C, Boenzi S, Baiocco F, Sabetta G, Dionisi-Vici C (2002) Successful pregnancy in a woman with mut- methylmalonic acidaemia. J Inherit Metab Dis 25:133–134PubMedCrossRef

Diss E, Iams J, Reed N, Roe DS, Roe C (1995) Methylmalonic aciduria in pregnancy: a case report. Am J Obstet Gynecol 172:1057–1059PubMedCrossRef

Drummond JT, Matthews RG (1994) Nitrous oxide degradation by cobalamin-dependent methionine synthase: characterization of the reactants and products in the inactivation reaction. Biochemistry 33:3732–3741PubMedCrossRef

Enns GM, Barkovich AJ, Rosenblatt DS, Fredrick DR, Weisiger K, Ohnstad C, Packman S (1999) Progressive neurological deterioration and MRI changes in cblC methylmalonic acidaemia treated with hydroxocobalamin. J Inherit Metab Dis 22:599–607PubMedCrossRef

Felmet K, Robins B, Tilford D, Hayflick SJ (2000) Acute neurologic decompensation in an infant with cobalamin deficiency exposed to nitrous oxide. J Pediatr 137:427–428PubMedCrossRef

Fowler B, Jakobs C (1998) Post- and prenatal diagnostic methods for the homocystinurias. Eur J Pediatr 157(Suppl 2):S88–S93PubMedCrossRef

Fowler B, Leonard JV, Baumgartner MR (2008) Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis 31:350–360PubMedCrossRef

Francis PJ, Calver DM, Barnfield P, Turner C, Dalton RN, Champion MP (2004) An infant with methylmalonic aciduria and homocystinuria (cblC) presenting with retinal haemorrhages and subdural haematoma mimicking non-accidental injury. Eur J Pediatr 163:420–421PubMedCrossRef

Frattini D, Fusco C, Ucchino V, Tavazzi B, Della Giustina E (2010) Early onset methylmalonic aciduria and homocystinuria cblC type with demyelinating neuropathy. Pediatr Neurol 43:135–138PubMedCrossRef

Freehauf CLJ, Wilman E, Wright JL, Van Hove E, Spector R. Gallagher & Thomas JA (2011) Use and benefit of a subcutaneous indwelling catheter for cobalamin administration in B12 responsive methylmalonic acidemia. In SIMD Annual Meeting, 16. Asilomar, Pacific Grove, CA

Froese DS, Healy S, McDonald M, Kochan G, Oppermann U, Niesen FH, Gravel RA (2010) Thermolability of mutant MMACHC protein in the vitamin B12-responsive cblC disorder. Mol Genet Metab 100:29–36PubMedCrossRef

Froese DS, Zhang J, Healy S, Gravel RA (2009) Mechanism of vitamin B12-responsiveness in cblC methylmalonic aciduria with homocystinuria. Mol Genet Metab 98:338–343PubMedCrossRef

Gerth C, Morel CF, Feigenbaum A, Levin AV (2008) Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type. J AAPOS 12:591–596PubMedCrossRef

Gold R, Bogdahn U, Kappos L, Toyka KV, Baumgartner ER, Fowler B, Wendel U (1996) Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onset. J Neurol Neurosurg Psychiatry 60:107–108PubMedCrossRef

Gravel RA, Mahoney MJ, Ruddle FH, Rosenberg LE (1975) Genetic complementation in heterokaryons of human fibroblasts defective in cobalamin metabolism. Proc Natl Acad Sci U S A 72:3181–3185PubMedCrossRef

Guigonis V, Fremeaux-Bacchi V, Giraudier S, Favier R, Borderie D, Massy Z, Mougenot B, Rosenblatt DS, Deschenes G (2005) Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation. Am J Kidney Dis 45:588–595PubMedCrossRef

Hannibal L, Kim J, Brasch NE, Wang S, Rosenblatt DS, Banerjee R, Jacobsen DW (2009) Processing of alkylcobalamins in mammalian cells: A role for the MMACHC (cblC) gene product. Mol Genet Metab 97:260–266PubMedCrossRef

Harding CO, Pillers DA, Steiner RD, Bottiglieri T, Rosenblatt DS, Debley J, Michael Gibson K (2003) Potential for misdiagnosis due to lack of metabolic derangement in combined methylmalonic aciduria/hyperhomocysteinemia (cblC) in the neonate. J Perinatol 23:384–386PubMedCrossRef

Houeto P, Borron SW, Sandouk P, Imbert M, Levillain P, Baud FJ (1996) Pharmacokinetics of hydroxocobalamin in smoke inhalation victims. J Toxicol Clin Toxicol 34:397–404PubMedCrossRef

Huemer M, Simma B, Fowler B, Suormala T, Bodamer OA, Sass JO (2005) Prenatal and postnatal treatment in cobalamin C defect. J Pediatr 147:469–472PubMedCrossRef

Kim J, Gherasim C, Banerjee R (2008) Decyanation of vitamin B12 by a trafficking chaperone. Proc Natl Acad Sci U S A 105:14551–14554PubMedCrossRef

Kim J, Hannibal L, Gherasim C, Jacobsen DW, Banerjee R (2009) A human vitamin B12 trafficking protein uses glutathione transferase activity for processing alkylcobalamins. J Biol Chem 284:33418–33424PubMedCrossRef

Kind T, Levy J, Lee M, Kaicker S, Nicholson JF, Kane SA (2002) Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. J Pediatr Hematol Oncol 24:327–329PubMedCrossRef

Kinsella LJ, Green R (1995) 'Anesthesia paresthetica': nitrous oxide-induced cobalamin deficiency. Neurology 45:1608–1610PubMed

Laframboise R, Cooper BA, Rosenblatt DS (1992) Malabsorption of vitamin B12 from the intestine in a child with cblF disease: evidence for lysosomal-mediated absorption. Blood 80:291–292PubMed

Lawson-Yuen A, Levy HL (2006) The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab 88:201–207PubMedCrossRef

Lerner-Ellis JP, Anastasio N, Liu J, Coelho D, Suormala T, Stucki M, Loewy AD, Gurd S, Grundberg E, Morel CF, Watkins D, Baumgartner MR, Pastinen T, Rosenblatt DS, Fowler B (2009) Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat 30:1072–1081PubMedCrossRef

Lerner-Ellis JP, Tirone JC, Pawelek PD, Dore C, Atkinson JL, Watkins D, Morel CF, Fujiwara TM, Moras E, Hosack AR, Dunbar GV, Antonicka H, Forgetta V, Dobson CM, Leclerc D, Gravel RA, Shoubridge EA, Coulton JW, Lepage P, Rommens JM, Morgan K, Rosenblatt DS (2006) Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet 38:93–100PubMedCrossRef

Levy HL, Mudd SH, Schulman JD, Dreyfus PM, Abeles RH (1970) A derangement in B12 metabolism associated with homocystinemia, cystathioninemia, hypomethioninemia and methylmalonic aciduria. Am J Med 48:390–397PubMedCrossRef

Linnell JC, Miranda B, Bhatt HR, Dowton SB, Levy HL (1983) Abnormal Cobalamin Metabolism in a Megaloblastic Child with Homocystinuria, Cystathioninuria and Methylmalonic Aciduria. J Inher Metab Dis 6:137–139CrossRef

Mamlok RJ, Isenberg JN, Rassin DK, Norcross K, Tallan HH (1986) A cobalamin metabolic defect with homocystinuria, methylmalonic aciduria and macrocytic anemia. Neuropediatrics 17:94–99PubMedCrossRef

Mansoor MA, Ueland PM, Aarsland A, Svardal AM (1993) Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria. Metabolism 42:1481–1485PubMedCrossRef

Martinelli D, Dotta A, Massella L, Picca S, Di Pede A, Boenzi S, Aiello C, & Dionisi-Vici C (2010) Cobalamin C defect presenting as severe neonatal hyperammonemia. Eur J Pediatr

McNeely JK, Buczulinski B, Rosner DR (2000) Severe neurological impairment in an infant after nitrous oxide anesthesia. Anesthesiology 93:1549–1550PubMedCrossRef

Mellman I, Willard HF, Youngdahl-Turner P, Rosenberg LE (1979) Cobalamin coenzyme synthesis in normal and mutant human fibroblasts. Evidence for a processing enzyme activity deficient in cblC cells. J Biol Chem 254:11847–11853PubMed

Merke DP, Bornstein SR (2005) Congenital adrenal hyperplasia. Lancet 365:2125–2136PubMedCrossRef

Mitchell GA, Watkins D, Melancon SB, Rosenblatt DS, Geoffroy G, Orquin J, Homsy MB, Dallaire L (1986) Clinical heterogeneity in cobalamin C variant of combined homocystinuria and methylmalonic aciduria. J Pediatr 108:410–415PubMedCrossRef

Morel CF, Lerner-Ellis JP, Rosenblatt DS (2006) Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. Mol Genet Metab 88:315–321PubMedCrossRef

Morel CF, Watkins D, Scott P, Rinaldo P, Rosenblatt DS (2005) Prenatal diagnosis for methylmalonic acidemia and inborn errors of vitamin B12 metabolism and transport. Mol Genet Metab 86:160–171PubMedCrossRef

Mudd SH, Levy HL, Abeles RH, Jennedy JP Jr (1969) A derangement in B 12 metabolism leading to homocystinemia, cystathioninemia and methylmalonic aciduria. Biochem Biophys Res Commun 35:121–126PubMedCrossRef

Nogueira C, Aiello C, Cerone R, Martins E, Caruso U, Moroni I, Rizzo C, Diogo L, Leao E, Kok F, Deodato F, Schiaffino MC, Boenzi S, Danhaive O, Barbot C, Sequeira S, Locatelli M, Santorelli FM, Uziel G, Vilarinho L, Dionisi-Vici C (2008) Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type. Mol Genet Metab 93:475–480PubMedCrossRef

Ogier de Baulny H, Gerard M, Saudubray JM, Zittoun J (1998) Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr 157(Suppl 2):S77–S83PubMedCrossRef

Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA, Sugiana C, Boneh A, Chen WK, Hill DE, Vidal M, Evans JG, Thorburn DR, Carr SA, Mootha VK (2008) A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112–123PubMedCrossRef

Patton N, Beatty S, Lloyd IC, Wraith JE (2000) Optic atrophy in association with cobalamin C (cblC) disease. Ophthalmic Genet 21:151–154PubMed

Pexa A, Fischer K, Deussen A, Henle T (2008) Homocysteine in food. Eur Food Res Technol 226:933–935CrossRef

Pierre G, Gissen P, Chakrapani A, McDonald A, Preece M, Wright J (2006) Successful treatment of pyridoxine-unresponsive homocystinuria with betaine in pregnancy. J Inherit Metab Dis 29:688–689PubMedCrossRef

Plesa M, Kim J, Paquette SG, Gagnon H, Ng-Thow-Hing C, Gibbs BF, Hancock MA, Rosenblatt DS, Coulton JW (2011) Interaction between MMACHC and MMADHC, two human proteins participating in intracellular vitamin B metabolism. Mol Genet Metab 102:139–148PubMedCrossRef

Powers JM, Rosenblatt DS, Schmidt RE, Cross AH, Black JT, Moser AB, Moser HW, Morgan DJ (2001) Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency. Ann Neurol 49:396–400PubMedCrossRef

Profitlich L, Kirmse B, Wasserstein MP, Diaz G, Srivastava S (2009a) Resolution of cor pulmonale after medical management in a patient with cblC-type methylmalonic aciduria and homocystinuria: a case report. Cases J 2:8603PubMedCrossRef

Profitlich LE, Kirmse B, Wasserstein MP, Diaz GA, Srivastava S (2009b) High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria. Mol Genet Metab 98:344–348PubMedCrossRef

Ribes A, Briones P, Vilaseca MA, Lluch M, Rodes M, Maya A, Campistol J, Pascual P, Suormala T, Baumgartner R (1990) Methylmalonic aciduria with homocystinuria: biochemical studies, treatment, and clinical course of a Cbl-C patient. Eur J Pediatr 149:412–415PubMedCrossRef

Richard E, Jorge-Finnigan A, Garcia-Villoria J, Merinero B, Desviat LR, Gort L, Briones P, Leal F, Perez-Cerda C, Ribes A, Ugarte M, Perez B (2009) Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC). Hum Mutat 30:1558–1566PubMedCrossRef

Robb RM, Dowton SB, Fulton AB, Levy HL (1984) Retinal degeneration in vitamin B12 disorder associated with methylmalonic aciduria and sulfur amino acid abnormalities. Am J Ophthalmol 97:691–696PubMed

Rosenblatt DS, Aspler AL, Shevell MI, Pletcher BA, Fenton WA, Seashore MR (1997) Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J Inherit Metab Dis 20:528–538PubMedCrossRef

Rosenblatt DS, Cooper BA (1987) Inherited disorders of vitamin B12 metabolism. Blood Rev 1:177–182PubMedCrossRef

Rossi A, Cerone R, Biancheri R, Gatti R, Schiaffino MC, Fonda C, Zammarchi E, Tortori-Donati P (2001) Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings. AJNR Am J Neuroradiol 22:554–563PubMed

Roze E, Gervais D, Demeret S, Ogier de Baulny H, Zittoun J, Benoist JF, Said G, Pierrot-Deseilligny C, Bolgert F (2003) Neuropsychiatric disturbances in presumed late-onset cobalamin C disease. Arch Neurol 60:1457–1462PubMedCrossRef

Schilling RF (1986) Is nitrous oxide a dangerous anesthetic for vitamin B12-deficient subjects? JAMA 255:1605–1606PubMedCrossRef

Selzer RR, Rosenblatt DS, Laxova R, Hogan K (2003) Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med 349:45–50PubMedCrossRef

Shinnar S, Singer HS (1984) Cobalamin C mutation (methylmalonic aciduria and homocystinuria) in adolescence. A treatable cause of dementia and myelopathy. N Engl J Med 311:451–454PubMedCrossRef

Smith DL, Bodamer OA (2002) Practical management of combined methylmalonicaciduria and homocystinuria. J Child Neurol 17:353–356PubMedCrossRef

Smith SE, Kinney HC, Swoboda KJ, Levy HL (2006) Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B12. Mol Genet Metab 88:138–145PubMedCrossRef

Smulders YM, Smith DE, Kok RM, Teerlink T, Swinkels DW, Stehouwer CD, Jakobs C (2006) Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap. Br J Haematol 132:623–629PubMedCrossRef

Spada M, Fowler B, Bonetti G, Battistoni G, Baglieri S, Perfetto F, Peduto A, & Ponzone A (1999) Fetal therapy in combined methylmalonic aciduria and homocystinuria. In SSIEM, 91. JIMD

Spector R (1979) Cerebrospinal fluid folate and the blood brain barrier. In: Botez M, Reynolds E (eds) Folic acid in neurology, psychiatry, and internal medicine. Reven Press, New York, pp 187–194

Strauss KA, Morton DH, Puffenberger EG, Hendrickson C, Robinson DL, Wagner C, Stabler SP, Allen RH, Chwatko G, Jakubowski H, Niculescu MD, Mudd SH (2007) Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab 91:165–175PubMedCrossRef

Surtees R (1998) Demyelination and inborn errors of the single carbon transfer pathway. Eur J Pediatr 157(Suppl 2):S118–S121PubMedCrossRef

Thauvin-Robinet C, Roze E, Couvreur G, Horellou MH, Sedel F, Grabli D, Bruneteau G, Tonneti C, Masurel-Paulet A, Perennou D, Moreau T, Giroud M, de Baulny HO, Giraudier S, Faivre L (2008) The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J Neurol Neurosurg Psychiatry 79:725–728PubMedCrossRef

Tomaske M, Bosk A, Heinemann MK, Sieverding L, Baumgartner ER, Fowler B, Trefz FK (2001) CblC/D defect combined with haemodynamically highly relevant VSD. J Inherit Metab Dis 24:511–512PubMedCrossRef

Tortorelli S, Turgeon CT, Lim JS, Baumgart S, Day-Salvatore DL, Abdenur J, Bernstein JA, Lorey F, Lichter-Konecki U, Oglesbee D, Raymond K, Matern D, Schimmenti L, Rinaldo P, Gavrilov DK (2010) Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry. J Pediatr 157:271–275PubMedCrossRef

Urbon Artero A, Aldana Gomez J, Reig Del Moral C, Nieto Conde C, Merinero Cortes B (2002) Neonatal onset methylmalonic aciduria and homocystinuria:Biochemical and clinical improvement with betaine therapy. An Esp Pediatr 56:337–341PubMed

Van Hove JL, Van Damme-Lombaerts R, Grunewald S, Peters H, Van Damme B, Fryns JP, Arnout J, Wevers R, Baumgartner ER, Fowler B (2002) Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy. Am J Med Genet 111:195–201PubMedCrossRef

Waclawik AJ, Luzzio CC, Juhasz-Pocsine K, Hamilton V (2003) Myeloneuropathy from nitrous oxide abuse: unusually high methylmalonic acid and homocysteine levels. WMJ 102:43–45PubMed

Wang F, Han LS, Hu YH, Yang YL, Ye J, Qiu WJ, Zhang YF, Gao XL, Wang Y, Gu XF (2009) Analysis of gene mutations in Chinese patients with methylmalonic acidemia and homocysteinemia. Zhonghua Er Ke Za Zhi 47:189–193PubMed

Weisfeld-Adams JD, Morrissey MA, Kirmse BM, Salveson BR, Wasserstein MP, McGuire PJ, Sunny S, Cohen-Pfeffer JL, Yu C, Caggana M, Diaz GA (2010) Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. Mol Genet Metab 99:116–123PubMedCrossRef

Wiley VC, Dudman NP, Wilcken DE (1988) Interrelations between plasma free and protein-bound homocysteine and cysteine in homocystinuria. Metabolism 37:191–195PubMedCrossRef

Willard HF, Ambani LM, Hart AC, Mahoney MJ, Rosenberg LE (1976) Rapid prenatal and postnatal detection of inborn errors of propionate, methylmalonate, and cobalamin metabolism: a sensitive assay using cultured cells. Hum Genet 34:277–283PubMedCrossRef

Yap S, Barry-Kinsella C, Naughten ER (2001) Maternal pyridoxine non-responsive homocystinuria: the role of dietary treatment and anticoagulation. BJOG 108:425–428PubMedCrossRef

Titel: Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management
verfasst von: Nuria Carrillo-Carrasco
Randy J. Chandler
Charles P. Venditti
Publikationsdatum: 01.01.2012
Verlag: Springer Netherlands
Erschienen in: Journal of Inherited Metabolic Disease / Ausgabe 1/2012
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-011-9364-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Amino acid metabolism in patients with propionic acidaemia

Combined OXPHOS complex I and IV defect, due to mutated complex I assembly factor C20ORF7

Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS)

Interrupting the mechanisms of brain injury in a model of maple syrup urine disease encephalopathy

Enzymology of the branched-chain amino acid oxidation disorders: the valine pathway

HSD10 disease: clinical consequences of mutations in the HSD17B10 gene

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin